Sex: U
Vaccine: COVID19
Symptoms: Computerised tomogram, Deep vein thrombosis, Pulmonary embolism, Thrombosis, Ultrasound scan
Clinical narrative: BILATERAL PULMONARY EMBOLISM; EXTENSIVE CLOTTING TO RIGHT LEFT AND ABDOMEN; DEEP VEIN THROMBOSIS; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. The patient's past medical history included four spine surgeries, and concurrent conditions included tendinosis, high blood pressure, type 2 diabetes, and platelet rich plasma therapy, and other pre-existing medical conditions included patient had no genetic conditions which would explain the clotting. patient had no prior history of blood clots. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown) dose was not reported, frequency 1 total, administered on 21-MAR-2021 for prophylactic vaccination. Batch number was not reported and has been requested. No concomitant medications were reported.  On 25-MAR-2021 and 1-APR-2021 patient underwent a series of Platelet Rich Plasma (PRP) Injections for left elbow for tendinosis. On 02-APR-2021, the patient experienced deep vein thrombosis and extensive clotting to right left and abdomen, and was hospitalized. Laboratory data included: Diagnostic ultrasound (NR: not provided) DVT and clot blood confirmed. Treatment medications included: heparin non-company. The patient was discharged on 03-APR-2021 with instructions to take Eliquis. On 07-APR-2021, the patient experienced bilateral pulmonary embolism and the patient was readmitted to the hospital. Laboratory data included: computed tomography (CT) scan (NR: not provided) Bilateral pulmonary embolism. Discharged on 09-APR-2021. On 23-APR-2021, Laboratory data included: Diagnostic ultrasound (NR: not provided) not provided. On 26-APR-2021, the patient was readmitted and thrombectomy was performed. The patient was discharged on 27-APR-2021. On 30-APR-2021, the patient experienced rethrombosis. Laboratory data included: Diagnostic ultrasound (NR: not provided) Rethrombosis confirmed. Treatment medications included: bivalirudin, where doctor placed a catheter and administered an Angiomax IV for 72 hours. On 03-MAY-2021, thrombolysis and thrombectomy surgery was performed. Patient was discharged on an unspcified date with additional treatment medications (dates unspecified) included: clopidogrel bisulfate, acetylsalicylic acid, and levofloxacin. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the extensive clotting to right left and abdomen, deep vein thrombosis, and bilateral pulmonary embolism was not reported. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V0: 20210525688-COVID-19 VACCINE AD26.COV2.S-extensive clotting to right left and abdomen, deep vein thrombosis, bilateral pulmonary embolism. This event(s) is considered not related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: MEDICAL HISTORY, UNDERLYING DISEASE